• COVID-19 Updates
  • InstaVisit 360° Virtual Tour
  • Blogs
  • Contact Us
Menu
  • COVID-19 Updates
  • InstaVisit 360° Virtual Tour
  • Blogs
  • Contact Us
Menu
  • About Us
    • Leadership
    • Awards And Recognitions​
    • Certifications
    • Quality Management
    • Environment, Health, Safety & Sustainability
    • Corporate Social Responsibility
  • Solutions
    • Small Molecules
    • Discovery
    • Chemistry
    • Biology
    • Safety Assessment
    • Computational & Data Sciences
    • SynVantage  
    • Development
    • Chemical development
    • Formulation development
    • Clinical Development
    • Analytical Development
    • Manufacturing
    • Commercial Manufacturing
    • Large Molecules
    • Discovery
    • Molecular Biology
    • Protein Sciences
    • Cell Line Development & Analysis
    • Antibody Generation
    • Development & Manufacturing
    • Development and Manufacturing Services
    • Analytical Characterization & Quality Control
    • Viral Testing & Clearance
    • Bioanalytical Laboratory Services
    • Synvent Integrated Drug Discovery
    • Other Drug Modalities
    • Peptides
    • Oligonucleotides
    • Antibody Drug Conjugates
    • PROTACs
    • CAR-T
    • Industries
    • Emerging Biopharma
    • Dedicated Centers
    • Center For Advanced Protein Studies (CAPS)
  • Investors
    • Overview
    • Investor Fact Sheet
    • Financial Information
    • Corporate Governance
      • Governance Structure
      • Board of Directors
      • Committees to the Board
      • Our Leadership
      • Corporate Structure
      • Governance Reports & Policies
    • Share holder services
    • Stock Exchange Disclosures
    • Analyst Coverage
    • Investor Calendar
    • Investor Contact
    • Annual Report 2020-21
    • ESG Report 2020-21
  • Careers
  • News & Events
    • Press Releases
    • In the Media
    • Events
  • Insights & Resources
    • Blogs
    • Brochures
    • Point Of View
    • Scientific Posters
    • Publications
    • Webinars
    • Case Studies
    • Videos
    • Life At Syngene
    • Newsletters
  • Group Companies
    • Biocon
    • Biocon Biologics
    • BICARA
    • Biocon Academy
  • COVID-19 Updates
  • InstaVisit
  • Contact Us
Search
Close
  • COVID-19 Updates
  • InstaVisit 360° Virtual Tour
  • Blogs
  • Contact Us
Menu
  • COVID-19 Updates
  • InstaVisit 360° Virtual Tour
  • Blogs
  • Contact Us
  • About Us
    • Leadership
    • Awards And Recognitions​
    • Certifications
    • Quality Management
    • Environment, Health, Safety & Sustainability
    • Corporate Social Responsibility
  • Solutions
    • Small Molecules
      • Discovery
        • Chemistry
        • Biology
        • Safety Assessment
        • Computational & Data Sciences
        • SynVantage 
        Development
        • Chemical Development
        • Formulation Development
        • Analytical Development
        • Clinical Development
        Manufacturing
        • Commercial Manufacturing
    • Large Molecules
      • Discovery
        • molecular biology
        • protein sciences
        • Cell line development & analysis
        • antibody generation
        Development & Manufacturing
        • Development and Manufacturing Services
        • Analytical Characterization & Quality Control
        • Viral Testing & Clearance
        • Bioanalytical Laboratory Services
        • Mammalian Gene to GMP timeline tool
    • Other Drug Modalities
        • Peptides
        • Oligonucleotides
        • Antibody Drug Conjugates
        • PROTACs
        • CAR-T
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

        Know More
        Know More
    • Industries
        • Animal Health
        • Pharmaceutical & Biotech
        • Agrochemical
        • Nutrition
        • Performance & Specialty Materials/Others
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

        Know More
        Know More
    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

        Know More
        Know More
    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

        Know More
        Know More
  • Investors
    • Investors
      • Overview
      • Investor Fact Sheet
      • Financial Information
      • Annual Report 2021-22
      • ESG Report 2020-21
      • Disclosures Under Regulation 46 Of The LODR
      Corporate Governance
      • Governance Structure
      • Board Of Directors
      • Committees To The Board
      • Our Leadership
      • Corporate Structure
      • Governance Reports & Policies
      • Share Holder Services
      • Stock Exchange Disclosures
      • Analyst Coverage
      • Investor Calendar
      • Investor Contact
  • Careers
  • News & Events
    • Press Releases
    • In the Media
    • Events
  • Insights & Resources
    • Blogs
    • Brochures
    • Points Of View
    • Scientific Posters
    • Publications
    • Webinars
    • Case Studies
    • White Papers
    • Videos
    • Life at Syngene
    • Newsletters
  • Group Companies
    • Biocon
    • Biocon Biologics
    • BICARA
    • Biocon Academy
Search
Close

Animal Health Innovation – Europe

Sign-up for our newsletter

© 2023. Syngene International Limited

Twitter Linkedin-in Youtube Facebook-f

Quick Links

  • About Us
  • Investors
  • Careers
  • News & Events
  • Insights & Resources
  • COVID-19 Updates
  • InstaVisit

Business

  • Discovery
  • Development
  • Manufacturing
  • SynVent Integrated Drug Discovery
  • Industries
  • Dedicated Centers
  • Center For Advanced Protein Studies (CAPS)

Get In Touch

  • Contact Us
  • Investor Contact

Other Links

  • Anti-Bribery Anti-Corruption Statement
  • Disclaimer
  • Privacy Policy
  • Cookie Policy
Twitter Linkedin-in Youtube Facebook-f

© 2023. Syngene International Limited

Download PDF
Download PDF

Your browser does not support this function.

To download, Please share your details

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements.

To find out more, read our Privacy Policy and Cookies Policy.

Close
Close

To view or email, Please share your details view

To download, Please share your details